Abiopharma

Clinical trial NCT07095127 updates: 1. completion date: 2026-12-31 → 2027-12-31 2. primary completion date: 2026-06-30 → 2027-06-30 3. enrollment: 10 → 30 participants

Clinical trial NCT06924320 updates: 1. start date: 2025-03-03 → 2025-03-06 2. completion date: 2027-03-15 → 2026-09-15 3. primary completion date: 2027-01-25 → 2026-09-15 4. enrollment: 132 → 381 participants 5. intervention model: PARALLEL → SEQUENTIAL

Clinical trial NCT00506870 updates: 1. primary purpose: not set → OTHER 2. collaborators added: Roche Diagnostics GmbH 3. collaborators removed: Hoffmann-La Roche

Clinical trial NCT05360446: enrollment: 610 → 608 participants.

Clinical trial NCT07205484: completion date: 2030-07-01 → 2030-03-01.

Clinical trial NCT06681324 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 30 → 24 participants 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT04269200 updates: 1. collaborators added: GOG Foundation, European Network of Gynaecological Oncological Trial Groups (ENGOT) 2. collaborators removed: The European Network for Gynaecological Oncological Trial groups (ENGOT), The Gynecologic Oncology Group (GOG) Foundation Inc

Clinical trial NCT05974579 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2025-03-31 → 2026-03-31 3. enrollment: 12 → 8 participants 4. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT05369429 updates: 1. completion date: 2026-06-01 → 2028-07-05 2. primary completion date: 2026-06-01 → 2028-07-05

Clinical trial NCT07101081 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-04-01 → 2026-04-23